Literature DB >> 11722430

Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus.

H A Papadaki1, D T Boumpas, F M Gibson, D R Jayne, J S Axford, E C Gordon-Smith, J C Marsh, G D Eliopoulos.   

Abstract

The changes in bone marrow (BM) stem cell reserve and function and stromal cell function in patients with active systemic lupus erythematosus (SLE) were investigated. The study was carried out on seven SLE patients and 28 healthy controls using flow cytometry and in vitro cell culture assays. We found that patients had low CD34(+) cells, compared with the control group, reflecting the decrease of both CD34(+)/CD38(-) and CD34(+)/CD38(+) cells. Patient CD34(+)/Fas(+) but not CD34(-)/Fas(+) cells were significantly increased. Apoptotic (7AAD(dim)) cells were higher among CD34(+)/Fas(+) than among CD34(+)/Fas(-) cells, and individual values of apoptotic CD34+ cells strongly correlated with the number of CD34(+)/Fas(+) cells. These findings are suggestive of a Fas-mediated apoptosis accounting for the low CD34(+) cells in SLE patients. Moreover, we found that patients had low numbers of granulocyte-macrophage colony-forming units (CFU-GM) and erythroid burst-forming units (BFU-E), compared with the control group, and that the generation of colony-forming cells in long-term BM cultures was significantly reduced. Patient BM stroma failed to support allogeneic progenitor cell growth. In one patient, CD34(+) cells were increased, apoptotic CD34(+)/Fas(+) cells were normalized and defective stromal cell function was restored after autologous stem cell transplantation. We concluded that defective haemopoiesis in SLE patients is probably caused, at least in part, to the presence of autoreactive lymphocytes in BM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722430     DOI: 10.1046/j.1365-2141.2001.03076.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  26 in total

1.  Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.

Authors:  Chong Chen; Yu Liu; Yang Liu; Pan Zheng
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  Suspects in the tale of lupus-associated thrombocytopenia.

Authors:  P D Ziakas; J G Routsias; S Giannouli; A Tasidou; A G Tzioufas; M Voulgarelis
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus.

Authors:  Alastair L Hepburn; Irvin A Lampert; Joseph J Boyle; Donna Horncastle; W Fai Ng; Mark Layton; Timothy J Vyse; Marina Botto; Justin C Mason
Journal:  Ann Rheum Dis       Date:  2007-02-02       Impact factor: 19.103

Review 4.  The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.

Authors:  Gholam-Hossein Alishiri; Amin Saburi; Noushin Bayat; Ali-Reza Saadat; Ehsan Saburi
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

Review 5.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

Review 6.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

Review 7.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

Authors:  Alexandre T J Maria; Marie Maumus; Alain Le Quellec; Christian Jorgensen; Danièle Noël; Philippe Guilpain
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

8.  Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.

Authors:  S G Thacker; D Duquaine; J Park; M J Kaplan
Journal:  Lupus       Date:  2010-01-12       Impact factor: 2.911

Review 9.  Endothelial progenitor cell dysfunction in rheumatic disease.

Authors:  Peter E Westerweel; Marianne C Verhaar
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

10.  Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures.

Authors:  Magdalene Nakou; Nicholas Knowlton; Mark B Frank; George Bertsias; Jeanette Osban; Clayton E Sandel; Helen Papadaki; Amalia Raptopoulou; Prodromos Sidiropoulos; Iraklis Kritikos; Ioannis Tassiulas; Michael Centola; Dimitrios T Boumpas
Journal:  Arthritis Rheum       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.